Fight against cancer: GE Healthcare collaborates with Nigeria Sovereign Investment Authority (NSIA) to advance early cancer detection in Nigeria

GE Healthcare (www.GEHealthcare.com) has partnered with the Nigeria Sovereign Investment Authority (NSIA) to supply latest technology in computed tomography (CT), Discovery RT, to Lagos University Teaching Hospital for its modern NSIA- LUTH Cancer Center, commissioned by President Muhammadu Buhari.
The Discovery RT, a simulation CT machine, is the first of such technology to be installed in the country. It enables physicians to study the body in detail allowing them to determine the exact location, shape, and size of the tumor to be treated. As part of the partnership, GE Healthcare will also provide servicing of the equipment and deliver hands-on training for the hospital’s radiology staff on the new technology.
Nigeria currently has eight public and one private comprehensive cancer care centers to serve its growing population of over 180 million people. Many of the public cancer centers have radiotherapy machines that are outdated, making access to radiation therapy more difficult for cancer patients. The new Radiotherapy Centre will increase access to quality services for the patients across Lagos state. This will help early detection and treatment of cancer, which improves chances of its being cured.
“For many years, GE Healthcare has developed tools that help improve the care of patients through advanced technologies that facilitate the diagnosis as well as help the fight against diseases such as cancer. We are happy to collaborate with NSIA in this landmark achievement for Nigeria in progressing the availability of world-class radiotherapy for cancer patients in the region. This will help improve the overall results in the fight against cancer, as well as in improving the quality of life”, said Eyong Ebai, General Manager for West Central and French Sub-Sahara Africa at GE Healthcare.The World Health Organization (WHO) projects that by 2030, between 10 and 11 million cancers will be diagnosed in low and middle-income countries.
About GE Healthcare: GE Healthcare (www.GEHealthcare.com) is the $19 billion healthcare business of GE (NYSE: GE).  As a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services.  With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, the company helps improve outcomes more efficiently for patients, healthcare providers, researchers and life sciences companies around the world.  Follow us on Facebook (https://bit.ly/2gP6DGb), LinkedIn (https://bit.ly/2H7gZh0), Twitter (https://bit.ly/1i9iyVT) and The Pulse (https://bit.ly/1euEpYu) for latest news, or visit our website www.GEHealthcare.com for more information.

Share this PostFacebooktwittergoogle_pluspinterestlinkedinmail
Connect with UsFacebooktwittergoogle_pluspinterestlinkedin

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Send in Your Business News to BusinessTrumpet News!